Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Study of Darvadstrocel for Complex Perianal Fistulas in Pediatric Crohn's Disease
2020-003193-48Phase 3Active
- Sponsor
- Takeda
- Start
- Oct 2020
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of darvadstrocel in Crohn's disease and anal fistula, sponsored by Takeda. Primary endpoint: Combined remission at Week 24. Started Oct 2020; status: active.
02
Drugs
darvadstrocel
03
Conditions
Crohn's diseaseanal fistula
Beyond the preview
Go deeper on 2020-003193-48.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-003193-48.